BalchC.M., SoongS-J, GershenwaldJ.E.Prognostic Factors Analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.J Clin Oncol2001; 19: 3622–34.
9.
PiccirilloJ.F., FeinsteinA.R.Clinical symptoms and comorbidity: significance for the prognostic classification of cancer.Cancer1996; 77: 834–42.
10.
BeggC.B., CramerL.D., HoskinsW.J., BrennanM.F.Impact of hospital volume on operative mortality for major cancer surgery.JAMA1998; 280: 1747–51.
11.
HillnerB.E., SmithT.J., DeschC.E.Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care.J Clin Oncol2000; 18: 2327–40.
12.
FreemanH.P.Poverty, culture and social injustice: determinants of cancer disparities.CA Cancer J Clin2004; 54: 72–7.
SingletaryS.E., GreeneF.L., SobinL.H.Classification of isolated tumor cells: clarification of the 6th edition of the AJCC Cancer Staging Manual.Cancer2003; 98: 2740–1.
15.
WinchesterD.P., StewartA.K., BuraC., JonesR.S.The National Cancer Data Base: a clinical surveillance and quality improvement tool.J Surg Oncol2004; 85: 1–3.
16.
GreeneF.L., StewartA.K., NortonH.J.A new TNM staging strategy for node-positive (Stage III) colon cancer. An analysis of 50,042 patients.Ann Surg2002; 236: 416–21.
17.
GreeneF.L., StewartA.K., NortonH.J.New tumor-node-metastasis staging strategy for node-positive (Stage III) rectal cancer: An analysis.J Clin Oncol2004; 22: 1778–84.
18.
GreeneF.L., SobinL.H.The TNM system: Our language for cancer care.J Surg Oncol2002; 80: 119–20.